Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
1.770
+0.120 (7.27%)
Sep 5, 2025, 4:00 PM - Market closed

Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $3.85 million. The enterprise value is $32.17 million.

Market Cap3.85M
Enterprise Value 32.17M

Important Dates

The last earnings date was Thursday, August 14, 2025, before market open.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Jaguar Health has 2.17 million shares outstanding. The number of shares has increased by 26.38% in one year.

Current Share Class 2.17M
Shares Outstanding 2.17M
Shares Change (YoY) +26.38%
Shares Change (QoQ) +61.94%
Owned by Insiders (%) 2.39%
Owned by Institutions (%) 2.15%
Float 1.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.23
Forward PS 0.24
PB Ratio 0.49
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 4.44.

Current Ratio 0.95
Quick Ratio 0.12
Debt / Equity 4.44
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -319.25% and return on invested capital (ROIC) is -45.30%.

Return on Equity (ROE) -319.25%
Return on Assets (ROA) -37.42%
Return on Invested Capital (ROIC) -45.30%
Return on Capital Employed (ROCE) -172.43%
Revenue Per Employee $241,020
Profits Per Employee -$829,490
Employee Count49
Asset Turnover 0.22
Inventory Turnover 0.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -93.68% in the last 52 weeks. The beta is 0.60, so Jaguar Health's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -93.68%
50-Day Moving Average 2.19
200-Day Moving Average 11.47
Relative Strength Index (RSI) 39.91
Average Volume (20 Days) 147,143

Short Selling Information

The latest short interest is 30,894, so 1.42% of the outstanding shares have been sold short.

Short Interest 30,894
Short Previous Month 44,024
Short % of Shares Out 1.42%
Short % of Float 2.03%
Short Ratio (days to cover) 0.32

Income Statement

In the last 12 months, Jaguar Health had revenue of $11.81 million and -$40.65 million in losses. Loss per share was -$26.56.

Revenue11.81M
Gross Profit 9.67M
Operating Income -32.85M
Pretax Income -38.32M
Net Income -40.65M
EBITDA -30.94M
EBIT -32.85M
Loss Per Share -$26.56
Full Income Statement

Balance Sheet

The company has $2.21 million in cash and $30.53 million in debt, giving a net cash position of -$28.32 million or -$13.02 per share.

Cash & Cash Equivalents 2.21M
Total Debt 30.53M
Net Cash -28.32M
Net Cash Per Share -$13.02
Equity (Book Value) 6.88M
Book Value Per Share 3.60
Working Capital -1.32M
Full Balance Sheet

Cash Flow

Operating Cash Flow -27.68M
Capital Expenditures n/a
Free Cash Flow -27.68M
FCF Per Share -$12.73
Full Cash Flow Statement

Margins

Gross Margin 81.88%
Operating Margin -278.13%
Pretax Margin -350.64%
Profit Margin n/a
EBITDA Margin -261.96%
EBIT Margin -278.13%
FCF Margin n/a

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.38%
Shareholder Yield -26.38%
Earnings Yield -1,055.86%
FCF Yield -718.95%

Analyst Forecast

The average price target for Jaguar Health is $60.00, which is 3,289.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target $60.00
Price Target Difference 3,289.83%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date Mar 24, 2025
Split Type Reverse
Split Ratio 1:25

Scores

Jaguar Health has an Altman Z-Score of -12.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.31
Piotroski F-Score 4